China Resources Double-Crane Pharmaceutical Co., Ltd. held the 16th session of the sixth directorate meeting on June 9, 2014, which discussed and approved issues including the proposal of Zhang Wenzhou's resignation from the position of Independent Director, the proposal of recommendation of Wu Zhi'ang Independent Director and the proposal of adjusting members of Special Committees of Directorate.